Washington [US], January 19 (ANI): The United States is committed to providing additional one million COVID-19 vaccine doses to Afghanistan through COVAX, said US Secretary of State Antony Blinken.
New Delhi [India], January 18 (ANI): Following reports of unapproved COVID vaccines being given to 15-18 year age group, Bharat Biotech on Tuesday requested healthcare workers to ensure that only COVAXIN is administered to individuals of the group.
Washington [US], January 16 (ANI): As India achieved the milestone of cumulative vaccine coverage of 156 crores on the first anniversary of the nationwide COVID-19 vaccination drive that started on January 16, 2021, Dr Kutub Mahmoood, Scientist and Virologist from Washington, DC told ANI
New Delhi [India], January 14 (ANI): The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, sources
New Delhi [India], January 14 (ANI): The Union Health Ministry on Friday issued a clarification that there is no COVID-19 vaccine shortage in Maharashtra as it has over 24 lakh unutilized doses of Covaxin available with it and an additional 6.35 lakh doses have been received today.
New Delhi [India], January 14 (ANI): Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said.
New Delhi [India], January 14 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech on Thursday announced that its indigenously developed COVID-19 vaccine Coavaxin is now a universal vaccine for adults and children.
Mumbai (Maharashtra) [India], January 13 (ANI): Maharashtra is facing a shortage of Covaxin and Covishield, said state health minister Rajesh Tope on Thursday.
New Delhi [India], January 12 (ANI): Hyderabad-based Bharat Biotech on Wednesday claimed that its COVID vaccine Covaxin can neutralise both Delta and Omicron variants of coronavirus.
New Delhi [India], January 10 (ANI): Amid the surge in COVID-19 cases driven by the Omicron variant, India began administering 'precaution doses' to healthcare, frontline workers and senior citizens with comorbidities on Monday.
New Delhi [India], January 9 (ANI): The third dose of Covaxin holds promise, the Indian Council of Medical Research said on Sunday just a day before the government plans to administer 'precaution' doses of COVID-19 vaccines to frontline workers, healthcare workers and senior citizens with